ACC inhibitor combination therapy for the treatment of non-alcoholic fatty liver disease

摘要

The present invention uses ACC inhibitors alone or in combination with one or more additional therapeutic agents to treat, stabilize, or reduce the severity or progression of non-alcoholic fatty liver disease Provide a method. A system for treating, stabilizing, or reducing the severity of non-alcoholic fatty liver disease, comprising a ACC inhibitor in combination with one or more additional therapeutic agents Also provide. Preferably, at least one of the one or more additional therapeutic agents is an antidiabetic agent.